Роман Владимирович Шевченко
Russian Medical Academy of Continuous Professional Education · 63 works · 131 citations · h-index 7
Top works
- Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease
- Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice
- Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats
- CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
- Drug–drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation
- Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease
- Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats
- Drug–drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation
- Экспериментальная фармакокинетика новых нейротропных пептидных лекарственных средств
- Preclinical Pharmacokinetics of GZK-111, a Dipeptide with Neuroprotective Activity
- Comparative Preclinical Pharmacokinetics and Bioavailability of Antidepressant GSB-106 Tablet Form
- Metabolism of a New Dipeptide Neuroprotector in Rats
- Quantification of Hexamethylenediamide Bis(N-Monosuccinyl-L-Glutamyl-L-Lysine) in Blood Plasma by HPLC–MS
- Preclinical pharmacokinetics of dipeptide with neuroprotective activity GZK-111
- Metabolism of a new dipeptide neuroprotector in rats
- HPLC-MS method development and validation for simultaneous quantitation of GZK-111 and CPG compounds in rat plasma
- Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation
- Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis
- Elimination Half-Life of Short Peptide Drugs in Humans Extrapolated From Animal Pharmacokinetic Pharmacokinetic Studies
- Фармакокинетика потенциального анксиолитика ГМЛ-1 у крыс